These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6208379)

  • 1. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.
    Boere WA; Harmsen T; Vinjé J; Benaissa-Trouw BJ; Kraaijeveld CA; Snippe H
    J Virol; 1984 Nov; 52(2):575-82. PubMed ID: 6208379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.
    Boere WA; Harmsen M; Kraaijeveld CA; Snippe H
    Arch Virol; 1986; 88(1-2):105-12. PubMed ID: 2420309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.
    Snijders A; Benaissa-Trouw BJ; Oosterlaken TA; Puijk WC; Posthumus WP; Meloen RH; Boere WA; Oosting JD; Kraaijeveld CA; Snippe H
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():557-65. PubMed ID: 1706409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    J Virol; 1985 May; 54(2):546-51. PubMed ID: 2985817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
    Fernández IM; Snijders A; Benaissa-Trouw BJ; Harmsen M; Snippe H; Kraaijeveld CA
    J Virol; 1993 Oct; 67(10):5843-8. PubMed ID: 7690411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.
    Boere WA; Benaissa-Trouw BJ; Harmsen M; Kraaijeveld CA; Snippe H
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1405-8. PubMed ID: 6854274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.
    Grosfeld H; Velan B; Leitner M; Cohen S; Lustig S; Lachmi BE; Shafferman A
    J Virol; 1989 Aug; 63(8):3416-22. PubMed ID: 2473217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodies.
    Oosterlaken TA; Kraaijeveld CA; Snijders A; Harmsen M; Benaissa-Trouw BJ; Snippe H
    Arch Virol; 1988; 100(1-2):115-20. PubMed ID: 2455492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus.
    Oosterlaken TA; Harmsen M; Tangerman C; Schielen P; Kraaijeveld CA; Snippe H
    J Immunol Methods; 1988 Dec; 115(2):255-61. PubMed ID: 3058808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2.
    Kaluza G; Repges S; McDowell W
    Virology; 1990 Jun; 176(2):369-78. PubMed ID: 1693245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
    Boere WA; Kraaijeveld CA; Snippe H
    Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
    [No Abstract]   [Full Text] [Related]  

  • 13. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
    Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
    Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in antigenicity of E2 in Semliki Forest virus particles and in infected cells.
    Repges-Illguth S; Kaluza G
    Arch Virol; 1994; 135(3-4):433-5. PubMed ID: 7526823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus.
    Oosterlaken TA; Harmsen M; Ekstijn GL; Kraaijeveld CA; Snippe H
    Immunology; 1992 Feb; 75(2):224-31. PubMed ID: 1551685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A shared idiotope among antibodies against Semliki Forest virus.
    Fernández IM; Ovaa W; Harmsen M; Benaissa-Trouw BJ; Bos NA; Kraaijeveld CA; Snippe H
    Viral Immunol; 1994; 7(2):71-80. PubMed ID: 7531444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein.
    Schmaljohn AL; Kokubun KM; Cole GA
    Virology; 1983 Oct; 130(1):144-54. PubMed ID: 6195815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.
    Ariel N; Lehrer S; Elhanaty E; Sabo T; Brodt P; Lachmi B; Katz D; Levin R; Grosfeld H; Velan B
    Arch Virol; 1990; 113(1-2):99-106. PubMed ID: 1696808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Semliki Forest virus in cell culture by use of an enzyme immunoassay with peroxidase-labeled monoclonal antibodies specific for glycoproteins E1 and E2.
    van Tiel FH; Boere WA; Vinjé J; Harmsen T; Benaissa-Trouw BJ; Kraaijeveld CA; Snippe H
    J Clin Microbiol; 1984 Sep; 20(3):387-90. PubMed ID: 6386855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural rearrangement of infecting Sindbis virions at the cell surface: mapping of newly accessible epitopes.
    Meyer WJ; Johnston RE
    J Virol; 1993 Sep; 67(9):5117-25. PubMed ID: 7688818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.